Skip to content

WHWK WHWK Accounts Receivable

Accounts Receivable at other companies

Eli Lilly logo
Eli LillyLLY
$18.43B+53.1%
Pfizer logo
PfizerPFE
$12.59B+6.2%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$5.73B+3.1%
Gilead Sciences logo
Gilead SciencesGILD
$5.54B+5.5%
AbbVie logo
AbbVieABBV
$12.48B0.0%
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
$646K-67.0%

Other financials

Income statement

See full
Revenue--100%
Gross profit--100%
Operating income-$23.5M-54.6%
Net income-$22.2M-130%
EPS (diluted)-$0.32-117%

Balance sheet

See full
Cash & equivalents$34.8M-84.7%
Total debt$833.0K-34.3%
Total equity$116.2M-47.6%
Total assets$127.2M-45.6%

Cash flow

See full
Operating cash flow-$22.2M-87.2%
CapEx--100%
Free cash flow-$22.2M-78.9%

Valuation

See full
Market cap$226.49M+131%

Profitability

See full
Gross margin89.4%+1.0pp
Operating margin-1,601.1%-1,985pp
Net margin-288.3%+61.6pp
FCF margin-1,371.4%-1,730pp

Returns & leverage

See full
Return on equity-68.5%-86.2pp
Debt / equity0.0×
Current ratio11.4×-7.6×

Where this comes from

Reported directly by WHWK in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: WHWK’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about WHWK's accounts receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is WHWK's accounts receivable?
WHWK (WHWK) reported accounts receivable of $0 in Q1 2026.
What is the long-term trend for WHWK's accounts receivable?
Over 3 years (2021 to 2025), WHWK's accounts receivable has grown at a -100.0% compound annual growth rate (CAGR), from -$10.61M to $0.
What does accounts receivable mean?
Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.